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As a biomaterial, chitosan has been widely used in tissue engineering, wound healing,
drug delivery, and other biomedical applications. It can be formulated in a variety of
forms, such as powder, film, sphere, gel, and fiber. These features make chitosan an
almost ideal biomaterial in cell culture applications, and cell cultures arguably constitute
the most practical way to evaluate biocompatibility and biotoxicity. The advantages of cell
cultures are that they can be performed under totally controlled environments, allow high
throughput functional screening, and are less costly, as compared to other assessment
methods. Chitosan can also be modified into multilayer composite by combining with
other polymers and moieties to alter the properties of chitosan for particular biomedical
applications. This review briefly depicts and discusses applications of chitosan and
nanoparticles in cell culture, in particular, the effects of chitosan and nanoparticles on
cell adhesion, cell survival, and the underlying molecular mechanisms: both stimulatory
and inhibitory influences are discussed. Our aim is to update the current status of how
nanoparticles can be utilized to modify the properties of chitosan to advance the art of
tissue engineering by using cell cultures.
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INTRODUCTION
Chitosan, produced by deacetylation of chitin, is a presumed
non-toxic and hydrophilic polysaccharide (Tomihata and Ikada,
1997; Fukuda et al., 2006). Commercially, chitin and chitosan are
obtained from shellfish sources such as crabs and shrimps. Chitin
was first discovered by the French scientist Henri Braconnot in
1811 and “modified chitin” was renamed “chitosan” by Hoppe-
Seiler in 1894 (Winterowd and Sandford, 1995). Research on
chitin and chitosan accelerated in the 1900s and recently hun-
dreds of articles have been published on chitosan. Bioapplications
of chitosan were probably more popularized in the last 25 years;
chitosan is currently better known to be a dietary supplement to
the public than its other biomedical applications. Because of its
low cost, large-scale availability, anti-microbial activity, as well
as biodegradation and biocompatibility (Khor and Lim, 2003),
chitosan has been widely used by researchers as an important
and promising biomaterial in tissue engineering (Dorj et al.,
2012; Hu et al., 2012), wound healing (Charernsriwilaiwat et al.,
2012; Wang et al., 2012), drug delivery (Chen et al., 2012a; Liang
et al., 2012), and other biomedical applications (Amarnath et al.,
2012; Kumar et al., 2012). Other important properties of chitosan
include its compatibility to natural glycosaminoglycan (GAG)
(Muzzarelli et al., 2005; Bhardwaj and Kundu, 2012) and that
it can be molded into a variety of forms, such as powder, film,
sphere, gel, and fiber. These compelling features are important
qualities in cell culture. Many researchers have chosen chitosan
or the combinations of chitosan with other materials to culture
different cell types (Khor and Lim, 2003; Charernsriwilaiwat et al.,
2012).
Recently adding nanoparticles in cell cultures for treatments
and therapeutic uses is among the newest developments other
than probing and imaging in nanotechnology and biotechnology.
Nanotechnology, first appeared in the twentieth century, is an area
of science devoted to the manipulation of atoms and molecules of
materials in the nanometer range. Nanoparticles include all par-
ticles that possess at least one dimension that is less than 100 nm:
the material origins of the particles can be organic, inorganic,
metals, polymers, etc. Because of the wide-range of potential
applications, nanotechnology has recently emerged as one of
the most commercially viable technologies. Nanoparticles possess
unique properties, more importantly, a large surface-to-volume
ratio; thus, many of these particles possess high surface reactivity.
These favorable properties are being exploited in many direc-
tions in science and technology, more so recently in biomedical
applications.
Nanoparticles can enter the body through the lung and skin
by absorption or through the gastrointestinal track via intake of
food, drink, and medication. Due to the ubiquitous existence of
nanoparticles and other nanomaterials, human exposure to these
nanoparticles is inevitable. Nanoparticles can enter and affect
different organs and tissues such as brain, liver, kidney, heart,
blood, etc., and induce cytotoxic effects (Lai et al., 2008b). These
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particles may alter and inhibit cell growth leading to various
pathophysiological states in humans and animals. Consequently,
nanotoxicology research is now gaining much more attention and
its importance is gradually being recognized.
Cell culture can be used to investigate cytotoxicity of nanopar-
ticles including their effects on cell adhesion, cell survival, etc.
Cell cultures in vitro can be performed under controlled environ-
ments with predictable and reproducible results, and are relatively
inexpensive. Hence, research studies using nanoparticles in cell
cultures have drawn considerable interest recently.
Combinations of material science in biological field proved
to be fruitful and promise to hold great potential in biomedi-
cal developments: In 2004, Gu et al. (2004) induced proliferation
of hepatocytes by immobilizing these cells on 24-nm gold col-
loids; they also constructed a silver nanocrystalline chitosan for
wound dressing (Lu et al., 2008). In 2009, they found that the
gold colloid/chitosan scaffold could promote adhesion and pro-
liferation of keratinocytes (Zhang et al., 2009; Lu et al., 2010).
Commercialization of these new technologies is sprouting almost
as fast as they are developed, such as some of the wound dress-
ing materials associated with nanoparticles (Rustogi et al., 2005;
Ulkur et al., 2005).
In the biological and biomedical fields, studies involving chi-
tosan, nanoparticles, or cell cultures alone are numerous in the
literature. As the science of nanotechnology continues to advance,
researchers are exploring different ways to modify chitosan for
various biomedical applications. Moderate amount of work thus
far has been performed to evaluate the biocompatibility of chi-
tosan and modified chitosan in cell cultures, especially cultures of
fibroblasts.
Applications of chitosan and its modified forms to tissue
engineering is a fast developing field. This review highlights appli-
cations of chitosan and nanoparticles in cell cultures, in particular
the effects of chitosan and nanoparticles on cell adhesion and cell
survival: both stimulatory and inhibitory influences are discussed.
Our aim is to update the current status of how nanoparticles can
be utilized to modify the properties of chitosan to advance the art
of tissue engineering (Lai et al., 2011) by using cell cultures.
USES OF CHITOSAN IN CELL CULTURES
DEACETYLATION OF CHITOSAN
Many studies showed that the degree of deacetylation and vari-
ation in molecular weights are the two factors that determined
the effects of chitosan on cell growth. Generally, chitosan dis-
solves in dilute acidic solutions such as HCl, acetic acid, and
some other organic acids (Sashiwa et al., 2000). Howling et al.
(2001) examined the effects of chitin and chitosan solution at
various deacetylation levels (37%, 58%, and 89%), molecular
weights (12,000–263,800 Da), as well as different concentrations
(2.5–500μg/mL) on the proliferation of human dermal fibrob-
lasts and immortalized human keratinocytes (HaCaT) in vitro.
Their study showed that at high degrees of deacetylation, chi-
tosan stimulated fibroblast proliferation better than chitosan with
lower levels of deacetylation; but the effects on keratinocytes were
different. At high levels of deacetylation (89% deacetylated), chi-
tosan inhibited HaCaT proliferation up to about 26%, while at
lower degrees of deacetylation (37% deacetylated), chitosan had
no effect on HaCaT proliferation at the reported concentrations.
These findings indicated that the deacetylation level of chitosan
is a key factor in regulating the mitogenic activity of fibroblasts
and keratinocytes, but the cell responses with molecular weight
differential was not clearly delineated in the report.
MODIFICATIONS OF CHITOSAN AND ITS PROPERTIES
Modification of chitosan either by substituting the surface func-
tional groups or cross-linking chitosan with different layers
of polymers can alter the mechanical and biological proper-
ties of chitosan. Chen et al. (2002) investigated the effects of
carboxymethyl (CM)-chitosan at different concentrations (50–
500μg/mL) and different molecular weights (3,200Da, 15,000 Da
and 35,000 Da) on normal human skin fibroblast and keloid
fibroblast. They showed that CM-chitosan promoted prolifera-
tion of normal skin fibroblast significantly but inhibited prolifera-
tion of keloid fibroblast, because the CM-chitosan could decrease
the ratio of type I/III collagen in keloid fibroblast by suppressing
the secretion of type I collagen; but CM-chitosan had no effect on
the secretion of types I and III collagen in the normal skin fibrob-
last. While both high and low concentrations of the CM-chitosan
promoted initial proliferation, they noted that at the high concen-
tration (500μg/mL), CM-chitosan exerted a more positive effect
on initial cellular proliferation. On the other hand, at the lower
concentration (100μg/mL), CM-chitosan exerted a lower posi-
tive effect, compared to that of the higher concentration on initial
cellular proliferation. Nevertheless, the duration of the effect
exerted at the lower CM-chitosan concentration was longer than
that achieved at the higher CM-chitosan concentration. In addi-
tion, molecular weight made no difference in growth stimulation
for the skin fibroblast, the lower molecular weight (3,200 Da)
CM-chitosan exerted almost the same effect on the growth stim-
ulation of normal skin fibroblast as that achieved by the higher
molecular weight (35,000 Da) CM-chitosan. However, the growth
inhibition of keloid fibroblast increased slightly with the decrease
of CM-chitosan molecular weight although that difference was
not significant (∼2%).
CELL CULTURES ON CHITOSAN FILM
CELL GROWTH ON CHITOSAN FILM
Chitosan solution can be employed to produce chitosan
film/membrane using solution-casting technique (Tomihata and
Ikada, 1997). This film can serve as a scaffold for cell cultures.
Fakhry et al. (2004) employed two kinds of commercially
available chitosan of different deacetylation and molecular
weights, Chitosan-H (molecular weight: 140,000 Da; degree of
deacetylation: 80%) and Protasan CL212 (molecular weight:
270,000 Da; degree of deacetylation: 70%), to prepare chi-
tosan film/membrane. They used these films to culture mouse
osteoblasts and fibroblasts and found that the two chitosan
films could enhance the initial attachment and proliferation of
osteoblasts, but the films were not as effective with fibroblasts.
Their observation indicated that manipulation of deacetylation
andmolecular size of chitosan could modulate the in vitro level of
cell attachment and spreading. Indeed, chitosan film inhibited the
proliferation and differentiation of embryonic rat cerebral corti-
cal single stem cells and neurosphere in serum-free medium; but
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when serum was included, it induced the neurosphere-forming
cells into an extensive cellular substratum of “protoplasmic cells”
on which process-bearing cells spread (Hung et al., 2006). Zheng
et al. (2003) studied the cytocompatibility of chitosan and CM-
chitosan in human skin fibroblasts. They found that chitosan film
inhibited cell growth and eventually the cells detached from the
film. By contrast, the skin fibroblasts adhered to and differentiated
well on CM-chitosan films. These findings demonstrated that
cytocompatibility of CM-chitosan films in fibroblasts was better
than that of plain chitosan films; these results were good examples
that cell proliferation and differentiation were controlled by com-
plex environmental conditions (stresses) that involve more than
just manipulation of cell types alone.
Lahiji et al. (2000) hypothesized that chitosan promotes the
survival and function of human osteoblasts and chondrocytes.
Human osteoblasts propagating on chitosan films continued to
express Type I collagen whereas chondrocytes expressed Type
II collagen. Their results demonstrated the biocompatibility of
chitosan as a substrate for the growth and continued function
of human osteoblasts and chondrocytes. Consequently, chitosan
shows some potential as a tissue engineering tool for the repair of
osseous and chondral defects.
The effects of hexanoyl chitosan (H-chitosan) on cytotoxicity,
attachment, proliferation, and spreading of L929 (mouse fibrob-
last) cells were reported (Neamnark et al., 2007). The attachment
of the cells on H-chitosan film was better than that on the chi-
tosan counterpart for a short time (<5 h) after seeding, while the
proliferation of the cells on H-chitosan film was better than that
on the chitosan counterpart after 2 and 3 days in culture.
To simulate a membrane layer that is closer to the natural
membrane that can be used as a structure scaffold and function as
a barrier with selectivity, a single layer material for such is nearly
impossible but a bilayer membrane is more realistic. A bilayer
structure of chitosan film and sponge as a scaffold can support
growth and proliferation of human neofetal dermal fibroblasts
(Ma et al., 2001). In fact, blendingmaterials with different chemi-
cal and physical properties (biocomposites) are finding numerous
applications in biomedical technology.
BLENDING POLYMERSWITH CHITOSAN AS CELL SCAFFOLD
To improve the biocompatibility and other properties (e.g., per-
meability) critical for a wide-range of biomedical applications,
blending chitosan with other polymers has been widely investi-
gated. Silica-chitosan complex membrane (SiCM) was developed
by Suzuki et al. (1999). The composition of the SiCM was step-
wisely controlled by adjustments of mixing ratios between silica
and chitosan from 0% to 50%. Their study showed that 50%
SiCM was especially effective in increasing adhesion and growth
of human embryonic kidney cells and human lung diploid cells.
Bettini et al. (2008) used sugar and phosphate to modify the chi-
tosan film: phosphate and sugar were added into the chitosan
film-forming solutions. The resulting chitosan film exerted a ben-
eficial effect on affinity with human diploid fibroblasts (HDF,
cell strain WI-38). A novel absorbable scaffold with an asym-
metric structure composed of chitosan and gelatin was fabricated
by a freezing and lyophilizing method as a bilayer skin substi-
tute (Mao et al., 2003). Data from that study suggested that
scaffold constructed by this artificial bilayerwas flexible, had good
mechanical properties and induced no contraction in the cell cul-
tures tested. Using the suspension of chitosan hydrogel mixed
with gelatin, novel chitosan/gelatin membranes were prepared
(Nagahama et al., 2009); human MG-63 osteoblast-like cells were
used to examine the effect of chitosan/gelatin membranes on cell
adhesion. The cells incubated with chitosan/gelatin membranes
for 24 h exhibited good adhesion to the chitosan/gelatin sub-
stratum, suggesting that these modified chitosan membranes are
useful for biomedical applications. Huang et al. (2005) investi-
gated the degradation of chitosan-gelatin scaffold and its effect on
mouse fibroblast activity and adhesion. The degradation rate and
material loss of chitosan-gelatin scaffold were faster than those
of chitosan alone even though both chitosan-gelatin and chi-
tosan alone supported fibroblast viability equally well. A similar
study was also performed by Chupa et al. (2000): they evaluated
the potential applications of GAG-chitosan and dextran sulfate
(DS, a semi-synthetic GAG analog)-chitosan complex membrane
materials for controlling the proliferation of human vascular
endothelial (EC) and smooth muscle cells (SMC). Their results
showed that while chitosan alone supported cell attachment and
growth, GAG-chitosanmaterials inhibited spreading and prolifer-
ation of ECs and SMCs in vitro. In contrast to the GAG-chitosan,
DS-chitosan supported proliferation of both cell types, although
it is a semi-synthetic GAG analog. Their results indicated that
GAG-chitosan could also be used to modulate the proliferation
of EC cells. A series of chitosan/poly-L-lysine composite films
were produced from chitosan/poly-L-lysine blended solutions by
Zheng et al. (2009) The effects of the composite films on the
behavior of MC3T3-E1 osteoblast-like cells (from mouse) were
assessed. Those researchers found that the increase in poly-L-
lysine weight fraction in the blended solutions could result in
different nanoscaled surface topographic features, and MC3T3-
E1 cells strongly responded to those nanotopographic features.
Consequently, their novel observation demonstrated nanotopog-
raphy of chitosan and chitosan-derived materials could exert
remarkable influences on behavior of cells cultured in vitro. Thus,
topographic modification of chitosan-derived substratum on a
nanoscale may be exploited in regulating behavior of cells in
culture, and as such can be productively exploited in diverse
applications in tissue engineering, as well as in engineering an
environment to foster bone regeneration.
Elastin and poly-L-lysine were used to modify a hybrid bulk
scaffold which contained polyethylene oxide, chitin, and chitosan
(Kuo and Chung, 2012). Bovine knee chondrocytes were seeded
in the scaffolds and cultured in a spinner-flask bioreactor over
4 weeks. Results of this study showed that elastin- and poly-L-
lysine-grafted polyethylene oxide/chitin/chitosan scaffolds were
effective in producing cartilaginous components. It appears that
modified chitosans have more and better control of biomedical
applications than just chitosan alone due to better physicochemi-
cal properties.
COMPLEX COMPOSITE MODIFICATIONS OF CHITOSAN FILM
Once chitosan is viewed as a building component of composite
materials for biomedical applications, the possibilities of creat-
ing new biocomposites with chitosan are almost unlimited. With
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such, majority of the new applications thus far are associated
with improving structural properties of scaffolding and tissue
connection. The following are some of the major applications of
chitosan biocomposites.
Applications with bone/cartilage
This constitutes another strategy to develop novel tissue engi-
neering applications. For example, Chen et al. (2006) utilized
fractional factorial design methodology to co-immobilized four
different GAGs (chondroitin-4-sulfate, chondroitin-6-sulfate der-
matan sulfate and heparin) and prepared eight different combina-
tions of GAG/chitosan membranes. They evaluated the effects of
these GAG/chitosan membranes on several properties of chon-
drocytes, including adhesion, morphology, and proliferation.
This was their attempt to provide a rational method to predict
and evaluate the proper formulation of GAG/chitosan mem-
branes for various applications in tissue engineering. Recently,
chitosan/chondroitin sulfate/nano-SiO2 composite scaffold was
fabricated by lyophilization (Kavya et al., 2012). Biocompatibility
and cell attachment-proliferation studies performed using MG-
63 cells (human osteosarcoma cell line) suggested this novel
nanocomposite scaffold could be a suitable candidate for bone
tissue engineering.
The polypeptide Arg-Gly-Asp-Ser (RGDS) sequence of
fibronectin was used to modify chitosan membrane using the
photochemical immobilization technique (Karakecili et al., 2007):
this substrate could enhance the attachment and proliferation of
L929 (mouse fibroblast) cells. Schneider et al. (2007) cross-linked
chitosan with hyaluronan (a polysaccharide) (CHI/HA) using
a water-soluble carbodiimide: the film had a much improved
elastic modulus and was more resistant to enzymatic degrada-
tion by hyaluronidase but was not overly thick. Consequently,
the increased film stiffness improved the adhesion and spread-
ing of chondrosarcoma cells. Thus, the CHI/HA cross-linked
films could be used for various biomedical applications due to
their more favorable mechanical and adhesive properties, and
are a more robust matrix material due to their higher toler-
ance to enzymatic degradation. Higher resistance to enzymatic
degradation allows the engineered tissue to develop into more
mature structure before the supportive scaffold collapsed. A series
of nano-hydroxyapatite/chitosan cross-linking composite mem-
branes (nano-hydroxyapatite; 0–30% by weight) were success-
fully developed by a simple casting/solvent evaporation method
by Li et al. (2012). The nano-hydroxyapatite content greatly
affected the morphology as well as the tensile property of com-
posite membrane. In vitro cytotoxicity testing suggested that
the developed nano-hydroxyapatite/chitosan cross-linking com-
posite membrane was non-cytotoxic to L929 cells after 24 h of
incubation. Therefore, the nano-hydroxyapatite/chitosan cross-
linking composite membrane with favorable cytocompatibility,
water adsorption (wettability) and tensile strength might serve as
the vehicle for bone tissue engineering.
Chitosan has also been employed to reinforce calcium phos-
phate cement (CPC). Moreau and Xu (2009) examined the pro-
liferation and osteogenic differentiation of mesenchymal stem
cells (MSCs) cultured on high-strength CPC-chitosan scaffold.
On the CPC-chitosan scaffold, MSCs differentiated into the
osteogenic lineage and expressed high levels of bone marker
alkaline phosphatase (ALP). The results of Moreau and Xu (2009)
suggested the stronger CPC-chitosan scaffold may be useful for
tissue engineering research in stem cell-based bone regeneration.
Alginate-chitosan semi-interpenetrating polymer network
(IPN) scaffolds were prepared by a freeze-drying process (Tigli
and Gumusderelioglu, 2009). The attachment and proliferation
abilities of ATDC5murine chondrogenic cells on alginate, 70:30%
(v/v) alginate:chitosan and 50:50% (v/v) alginate:chitosan scaf-
folds, were assessed. The results of this study indicated that
alginate:chitosan semi-IPN scaffolds could promote chondrocyte
proliferation and that 50:50% (v/v) alginate:chitosan scaffolds
showed some promise as an ideal material for applications in car-
tilage tissue engineering in vitro, especially from the prospective
of structural analysis and cell-based functional screening.
Venkatesan et al. (2012) constructed chitosan-carbon nan-
otube scaffolds by a freeze-drying method. Carbon nanotube was
uniformly dispersed in chitosan matrix. Cytotoxic effects and cell
proliferation of scaffold were investigated employing the MTT
assay using MG-63 cells (human osteosarcoma cell line). The
cell proliferation, protein content, ALP and mineralization of the
cells cultured on composite scaffolds were higher than those on
the chitosan scaffold due to the addition of carbon nanotube
suggesting that chitosan/f-MWCNT scaffolds may be promising
biomaterials for bone tissue engineering.
Applicationswith fibroblasts and other cell types
Chitosan can also be used to functionalize with other poly-
merizable molecules to improve the biocompatibility and
mechanical properties of the resulting copolymer, such as poly-
L-lactic acid, poly(L-lactide-co-epsilon-caprolactone) and poly
(ε-caprolactone) (Ding et al., 2004; Mei et al., 2005; Jiao et al.,
2007; Yang et al., 2012; Zhang and Cui, 2012). Immobilization of
chitosan onto poly-L-lactic acid (PLLA) film surface by plasma
graft polymerization has been reported. Two cell lines, L929
(mouse fibroblast) and L102 (human hepatocytes), were cultured
on the modified PLLA surface. Results indicated that cell spread-
ing on this film was minimal and the colonies tended to become
rounded. Thus, the film was demonstrated to be a poor adhering
substrate. Nonetheless, cells grown on this substrate proliferated
at almost the same speed as those cultured on a glass surface.
These results suggested that the new substrate could be used to
control the morphology of cells.
Another method to construct a novel cytocompatible graft co-
polymer of chitosan and L-lactic acid was reported by Yao et al.
(2003). They dissolved chitosan powder in an aqueous solution
of L-lactic acid and then poured the solution into a frame mold,
and maintained at a proper temperature for film formation. With
this type of co-polymer films, they were able to ascertain that
the growth rate of human fibroblast on the co-polymer films,
with various L-lactic acids to chitosan ratios, was higher than
that on chitosan alone, but the growth of those cells decreased
as the ratio of L-lactic acid to chitosan increased. All the copoly-
mer and chitosan films enhanced initial fibroblast proliferation,
but the proliferation of the cells on both types of films even-
tually became slower than that of the controlled cells cultured
after 9 days. Evidently, despite their results of slower cell growth
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at prolonged time, the co-polymer films provided a better scaf-
fold than chitosan alone with improved mechanical properties for
cell growth and thus could be useful in applications in designing
grafting in tissue engineering.
Keratin-chitosan film is another useful composite film fabri-
cated (Tanabe et al., 2002). This film was fabricated by mixing
solutions of keratin and chitosan casting into the polypropy-
lene mold, and then followed by drying at 50◦C overnight. With
this procedure, films with average 0.01–0.02mm thickness were
obtained. The role of chitosan was to reinforce the mechanical
properties of keratin film. Results of that study (Tanabe et al.,
2002) showed the keratin-chitosan film was a good substrate
that supported the attachment and proliferation of L929 mouse
fibroblast cells; this finding also suggested that keratin-chitosan
film could be a good supporting substrate for other mammalian
cells in culture.
Poly (vinyl alcohol) (PVA)/chitosan blend has also been fabri-
cated (Chuang et al., 1999). Human skin fibroblasts seeded and
cultured on the PVA/chitosan blended membrane showed better
attachment and spreading compared to that of fibroblasts seeded
and cultured on the pure PVA membrane alone (Chuang et al.,
1999). This observation suggested that chitosan enhanced the
biocompatibility of the PVA and that the PVA/chitosan blended
membrane could be employed as another useful biofilm for cell
culture applications. In 2009, Costa et al. (2009) and Mansur
et al. (2009) synthesized chitosan/PVA blends with different chi-
tosan/PVA mass ratios and chemically cross-linked these blends
with glutaraldehyde. VERO cells (isolated from kidney epithe-
lial cells from an African green monkey) were used to assess the
biocompatibility and cytotoxicity of these chitosan/PVA blends.
Their studies demonstrated that changing the mass ratio of chi-
tosan to PVA could alter the “swelling behavior” of the blended
materials. Swelling control is an important property for tissue
engineering that the physical performance of the materials must
be predictable. The results from cell biocompatibility assays have
demonstrated that all these blends were non-toxic and biotol-
erant and potentially suitable for prospective use in skin tissue
engineering and drug delivery.
THREE-DIMENSIONAL CELL CULTURE MATRICES
INVOLVING CHITOSAN GEL AND CHITOSAN
NANOPARTICLES/NANOFIBER COMPLEXES
CELL GROWTH IN 3-DIMENSIONAL CHITOSAN STRUCTURES
Under physiological conditions, cells normally proliferate and
grow in various organs and tissues in vivo in a truly three-
dimensional (3-D) matrix surrounded by one or more other cell
types (Lai and Leung, 2005; Zhang et al., 2005). Thus, a 3-D
in vitro cell culture environment more closely resembles that of
the in vivo physiological environment. Methods or materials fare
well in the 2-D setting may not fare well in the 3-D situation; one
of the major obstacles of 3-D culture is the delivery or availabil-
ity of nutrients that are needed for the cells to survive/proliferate.
Passive diffusion does not provide enough supports for the cells
in deep layers: this situation may not be as critical in 2-D cul-
ture. Indeed, the use of chitosan has been recently exploited to
create such an environment in vitro. For example, chitosan can
be made into a gel and/or nanoparticle/nanofiber complex that
can provide a 3-D structure. Poly (vinyl alcohol) (PVA)/chitosan
blended hydrogel has been fabricated for that purpose (Koyano
et al., 1998; Minoura et al., 1998). The hydrogel with 40%
(weight) chitosan content was superior to collagen for the attach-
ment and growth of L929 mouse fibroblasts. Karp et al. (2006)
created micropatterns in the chitosan gel using a photolitho-
graphic method which was simple and rapid. Cardiac fibrob-
lasts, cardiomyocytes and osteoblasts could form arrays on these
chitosan-patterned surfaces and remained stable for up to 18
days. Zheng et al. (2012) recently presented a new method for
primary neonatal rat cardiomyocytes cultured in vitro using algi-
nate/collagen/chitosan hydrogel. The results showed a significant
increase in cardiac myocyte numbers, and the expression levels
of CACNL1A1 and Connexin 43 were up-regulated significantly,
as compared with those in 2-D cultures. By using a electrospin-
ning technique, PCL (poly(ε-caprolactone))/chitosan/PCL scaf-
folds were prepared layer by layer (Sasmazel, 2011). The hybrid
scaffolds exhibited nanofiber structures and such layered scaf-
folds have provided improved substrate delivery to facilitate the
growth and differentiation of SaOs-2 osteosarcoma cells cul-
tured in vitro. A biomimetic poly(propylene carbonate) (PPC)
porous scaffold with nanofibrous chitosan network (PPC/CSNFs,
chitosan nanofibers) for bone tissue engineering was fabri-
cated by a dual solid-liquid phase separation technique (Zhao
et al., 2012). The in vitro culture of bone MSCs showed that
PPC/CSNFs scaffold exhibited a better cell viability than PPC
scaffold. Bhardwaj and Kundu (2012) fabricated polyelectrolyte
complex silk fibroin/chitosan blended porous scaffolds and exam-
ined its ability to support in vitro chondrogenesis of MSCs. These
results suggested that silk fibroin/chitosan blended 3D scaffolds
were suitable scaffold for mesenchymal stem cell-based carti-
lage repair. A similar study showed that silk fibroin/chitosan
composite nanofibers could support the growth and osteogenic
differentiation of human fetal osteoblastic cells, indicating that
these nanofibers would be potentially suitable for bone tissue
engineering applications (Chen et al., 2012b).
Fukuda et al. (2006) advanced the use of chitosan hydrogel in
the co-culture paradigm for cells from different animal species.
They synthesized a photo-cross-linkable chitosan using the pro-
tocol of Ono et al. (2000). Fukuda and co-workers demonstrated
human hepatocellular carcinoma (HepG2) cells and NIH-3T3
mouse fibroblasts could be co-cultured in the chitosan hydrogel
where the two cell types were spatially separated. They also noted
that the NIH-3T3 fibroblasts attached evenly to the chitosan sur-
face surrounding the HepG2 spheroids and proliferated over time
to cover the entire surface of the hydrogel.
Manipulating neural cells in culture has consistently pro-
vided challenges for tissue engineering researchers, not least of
all because of the paucity of existing appropriate neural cell
models in vitro (Lai and Leung, 2005; Zhang et al., 2005). On
the other hand, model systems in vivo have revealed significant
challenges that differ from those of in vitro models (Lai and
Leung, 2005; Zhang et al., 2005). Nevertheless, some advances
have been evident. Zahir et al. (2008) investigated the survival
and differentiation of neural stem/progenitor (NSPCs) cells cul-
tured on chitosan matrices in vivo in a complete transection
model of spinal cord injury. Firstly, they isolated NSPCs from
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the subependyma of lateral ventricles of adult green fluores-
cent protein (GFP)-transgenic rat forebrains, and then seeded
the GFP-positive neurospheres onto the inner lumen of chitosan
tubes to generate multicellular sheets ex vivo. Finally, they
implanted the bioengineered neurosphere tubes into a completely
transected spinal cord for 5 weeks and then assessed for cell sur-
vival and differentiation. They found that the implanted NSPCs
showed excellent survival; moreover, the implanted cells dif-
ferentiated into astrocytes and oligodendrocytes. These results
demonstrated that the chitosan tubes exhibited excellent potential
for use in stem cell delivery and neural regeneration. For neural
tissue engineering, hydrogel-based scaffolds can provide appro-
priate physicochemical and mechanical properties to support
neurite extension. Valmikinathan et al. (2012) developed a novel
chitosan-based photocrosslinkable hydrogel system with tun-
able mechanical properties and degradation rates. When human
MSCs were cultured in photocrosslinkable chitosan hydrogels,
negligible cytotoxicity was observed. Photocrosslinkable chitosan
hydrogels facilitated neural differentiation from primary corti-
cal neurons and enhanced neurite extension from dorsal root
ganglia as compared to agarose based hydrogels. These data
demonstrated the potential of photocrosslinked chitosan hydro-
gels designed for neural tissue engineering. Electrospun polyvinyl
alcohol (PVA)/chitosan nanofibrous scaffolds have been synthe-
sized (Alhosseini et al., 2012). The scaffolds were used for in vitro
cell culture in contact with PC12 cells which are neurons-like,
they were found to exhibit the most balanced physicochemical
and biological properties to meet the basic required specifica-
tions for nerve cells. Thus, it could be concluded that addition
of chitosan to the PVA scaffolds enhanced viability and prolifera-
tion of nerve cells, thereby confirming the biocompatibility of the
scaffolds. Therefore, PVA/chitosan nanofibrous scaffolds have the
potential to be used in nervous tissue engineering and repair.
The thermosensitive chitosan-gelatin-glycerol phosphate
hydrogels were synthesized so that they can be employed as a cell
carrier for nucleus pulposus (NP) cell regeneration (Cheng et al.,
2010). NP cells cultured in the hydrogels displayed normal GAG
production, mRNA production and gene expression. This finding
suggested that this hydrogel may be suitable for intervertebral
disc replacement in tissue engineering. Ma et al. (2010) prepared
injectable hydrogels from chitosan derivative, methacryloyloxy
ethyl carboxyethyl chitosan (EGAMA-CS)/polyethylene glycol
dimethacrylate (PEGDA)/N, N-dimethylacrylamide (DMMA)
by photopolymerization. Their cell culture studies demonstrated
that these hydrogels exhibited the desirable properties in pro-
moting attachment and proliferation of human bone sarcoma
(SW1353) cells. Thus, their results suggested that these hydrogels
may well be the ideal matrix material for bone tissue engineering.
More recently, porous chitosan-gelatin/hydroxyapatite composite
scaffolds were developed (Isikli et al., 2012). These scaffolds
promoted Saos-2 cells attachment and proliferation indicating
that scaffolds prepared from chitosan, gelatin and hydroxyapatite
were good cell carriers for bone tissue engineering.
An important issue to tissue engineering is the influence of
mechanical characteristics and matrix architecture of substrates
used in cell culture. Iyer et al. (2012) examined the influence of
porous structures, hydrogels (chitosan-gelatin), and membranes
of chitosan-basedmaterial on thegrowthofnormal humanfibrob-
lasts and their matrix production in a serum-free system. They
used chitosan alone and in combination with gelatin. They found
that increased viability of fibroblasts on chitosan gelatin porous
scaffold with decreased proliferation relative to tissue culture plas-
tic surface. The total protein, collagen and tropoelastin contents
were higher in the spent media derived from cells cultured with
chitosan gelatin porous scaffolds compared with corresponding
levels from cells treated with chitosan membrane or hydrogel
alone. An increase in collagen content was also observed in the
matrix, suggesting increasedmatrix deposition. Therefore, matrix
production is influenced by the formof chitosan structures, which
significantly affects the regenerative process.
EFFECTS OF CHITOSAN NANOPARTICLES ON CELLS IN CULTURE
Chitosan nanoparticles have been synthesized using either the
batch processing methods or the spinning disc processor (Bodna
et al., 2005; Loh et al., 2008). Evidence has shown that chitosan
nanoparticles may exert differential bactericidal and pharma-
cological effects on prokaryotic and eukaryotic cells in culture
(Shi et al., 2006; Grenha et al., 2007). Shi et al. showed that
chitosan nanoparticles had significant bactericidal effects on bac-
teria such as Staphylococcus aureus (S. aureus) and Staphylococcus
epidermidis (S. epidermidis), but had no cytotoxic effect on
mouse fibroblast cells (Shi et al., 2006). Grenha et al. also
demonstrated that chitosan nanoparticles are biocompatible with
human respiratory epithelial cells in vitro (Grenha et al., 2007).
Nevertheless, chitosan nanoparticles cannot be expected to be
biocompatible to all mammalian cell types. Materials that are
non-toxic at macroscale can become toxic at nanoscale (Rustogi
et al., 2005). Nafee et al. (2009) investigated the effects of the
chitosan/PLGA[Poly(D,L-lactide-co-glycolide)] nanoparticles on
three cell lines (i.e., African green monkey kidney COS-1 cells,
human alveolar cancer A549 cells and human bronchial epithe-
lial Calu-3 cells). These chitosan nanoparticles were cytotoxic to
COS-1 cells in a dose-related manner; however, they were not
cytotoxic to A549 cells in the dose range investigated. Similarly,
these chitosan nanoparticles were nearly non-cytotoxic to Calu-3
cells compared to COS-1 cells. Similar results were obtained by
employing different cytotoxic assays (e.g., MTT, LDH release) by
the investigators.
EFFECTS OF COLLAGEN-CHITOSAN NANOFIBERS
A few studies have focused on elucidating the effects of another
novel chitosan nanofiber, namely collagen-chitosan complex
nanofibers, which have been fabricated employing an eletrospin-
ning technique (Chen et al., 2007). Tangsadthakun et al. (2007)
investigated the influence of molecular weight of chitosan on
the physical and biological properties of collagen/chitosan scaf-
folds. They found that low-molecular-weight chitosan within the
collagen-chitosan nanofibers rendered the nanofibers more effec-
tive in promoting and accelerating the proliferation of mouse
L929 fibroblasts. Duan et al. (2006) constructed a nanofibrous
composite membrane of poly (lactide-co-glycolide) (PLGA)
and chitosan/poly(vinyl alcohol) (PVA) and tested their effects
on attachment and proliferation of rabbit dermal fibroblasts.
They concluded that the nanofibrous composite membrane
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they fabricated show a good tendency toward promoting the
attachment and proliferation of rabbit dermal fibroblasts and
suggested that the composite membrane was a good candidate
for application in skin tissue engineering/reconstruction. Feng
et al. (2009) developed a novel natural nanofibrous galactosylated
chitosan (GC) scaffold and investigated its effect on primary cul-
tures of rat hepatocytes. They observed that hepatocytes cultured
on GC nanofibrous scaffold formed stably immobilized 3-D flat
aggregates and exhibited superior bioactivity with higher levels of
liver-specific functions compared to the 3-D hepatocyte spheroid
aggregates formed on GC films alone. Consequently, their find-
ings pointed to the utility of the GC-based nanofibrous scaffolds
in the constructs of bioartificial liver-support devices and the
versatility of these scaffolds were also suitable as substrates for pri-
mary cultures of hepatocytes in tissue engineering applications,
such as liver regeneration and related translational research.
NANOPARTICLES AND CELL SURVIVAL
TOXICITY OF NANOPARTICLES AND RELATED NANOMATERIALS
Despite the important and accelerating advances of nanoscience
and nanotechnology, there has been increasing concern that some
of the nanomaterials are not as harmless as people have assumed.
Those concerns have spurred a new field of research, namely,
“nanotoxicology” (Jandhyam et al., 2008; Lai et al., 2008c).
Cell cultures of a variety of human and other mammalian cell
types constitute versatile model systems in vitro for high through-
put screening of putative toxicity of nanomaterials, including
nanoparticles, and for elucidating any underlying molecular
mechanisms (Rustogi et al., 2005; Jandhyam et al., 2008; Lai
et al., 2008c). The putative nanotoxicity of various nanomate-
rials has been examined: such nanomaterials included, but were
not limited to, carbon nanotubes (Agharkar et al., 2008), carbon
nanopipes (Whitby et al., 2008), silicon dioxide (Rustogi et al.,
2005) and many metal oxides.
In 2005, Limbach et al. (2005) evaluated the uptake and trans-
port of industrially important cerium oxide nanoparticles into
human lung fibroblasts in vitro by exposing them to suspensions
of these nanoparticles, with concentrations ranging from 100 ppb
to 100 ppm. At such low but pathophysiologically relevant con-
centrations, the size of the nanoparticles was a dominant factor
in determining the rate of uptake, while total particle surface area
was of secondary importance. In 2006, the same research group
employed a humanmesothelioma cell line and a rodent fibroblast
cell line to test the putative cytotoxicity in vitro of seven industri-
ally important soluble and insoluble nanoparticles, namely SiO2,
Ca3 (PO4)2, Fe2O3, ZnO, CeO2, TiO2, and ZrO2. They found that
solubility was the critical factor in determining the cytotoxicity of
the nanoparticles (Brunner et al., 2006). In 2011, Shavandi et al.
(2011) assessed the toxicity of silver nanoparticles in murine peri-
toneal macrophages. A significant decrease in cell viability was
observed at concentration of silver nanoparticles from 1 ppm to
25 ppm when the results were compared to that in the control
group after 24 h of exposure of the cells to the nanoparticles in
culture.
Lai and co-workers were the first to develop cell models in vitro
for high throughput screening of putative cytotoxicity of nano-
materials, including nanoparticles, in neural cells (Rustogi et al.,
2005; Lai et al., 2007, 2008a,c, 2009, 2010; Agharkar et al., 2008;
Jandhyam et al., 2008; Jaiswal et al., 2010, 2011; Jain et al., 2011;
Lu et al., 2011). Their comprehensive and systematic studies have
revealed that nanoparticles of metallic and non-metallic oxides
exerted differential cytotoxic effects on neural cells derived from
the central nervous system as cell models in vitro (Rustogi et al.,
2005; Lai et al., 2007, 2008a,c, 2009, 2010; Jandhyam et al., 2008).
More recently, they have also developed non-tumor neural cells
derived from the peripheral nervous system for high through-
put screening of putative cytotoxicity of nanomaterials, including
nanoparticles, on peripheral neural cells (Jaiswal et al., 2010,
2011; Jain et al., 2011; Lu et al., 2011). Results of their previ-
ous and ongoing studies have also indicated that nanoparticles
of metallic and non-metallic oxides exerted differential cytotoxic
effects on neural cells derived from the peripheral nervous system
(Jaiswal et al., 2010, 2011; Jain et al., 2011; Lu et al., 2011). Their
results (Rustogi et al., 2005; Lai et al., 2007, 2008a,c, 2009, 2010;
Jain et al., 2011; Jandhyam et al., 2008; Jaiswal et al., 2010, 2011;
Lu et al., 2011) have highlighted the importance and need for
screening and elucidating the putative cytotoxicity of nanopar-
ticles in neural cells if the nanoparticles are to be employed in
biomedical and other applications that exert impact on the ner-
vous system. Indeed, one emerging area where this nanotoxicity
concern needs to be adequately addressed is the area of targeted
drug delivery to the central nervous system and other peripheral
organs.
To enhance targeted drug delivery, nanoparticle-loaded poly-
mer capsules are often employed to enable selective drug delivery
to the desired target organ(s). In accord with the considera-
tions discussed above, prior to—at least along with—developing
the applications of nanoparticles for drug delivery, the puta-
tive nanotoxicity of such particles needs to be assessed. Some
examples of this kind of investigations are available in the litera-
ture. Kirchner et al. (2005a) demonstrated that polymer capsules
containing coating of CdTe nanoparticles exhibited higher toxic
effects than those of non-coated capsules. Nevertheless, by com-
parison, the silica-coated CdSe/ZnS nanoparticles were far less
cytotoxic (Kirchner et al., 2005b). On the other hand, not all
nanoparticles containing Si are benign and non-toxic. Di Pasqua
et al. (2008) assessed the cytotoxicity of MCM-41, a mesoporous
silica nanomaterial, in human neuroblastoma SK-N-SH cells.
They found that MCM-41 was more toxic than spherical sil-
ica (i.e., SiO2) nanoparticles. As we have alluded to above, SiO2
nanoparticles are known to be cytotoxic to neural and non-neural
cells (Rustogi et al., 2005; Lai et al., 2007, 2008a, 2010; Jandhyam
et al., 2008; Jain et al., 2011; Jaiswal et al., 2011).
APPLICATIONS OF NANOPARTICLES
Cyclodextrins (CDs) are cyclic oligosaccharides widely used in
pharmaceutical industries to control and/or improve on the sol-
ubility, release and absorption of drugs so as to ascertain the
proper delivery of such drugs. Thus, injectable CDs are use-
ful in drug delivery applications. Their utility notwithstanding,
one disadvantage of using CDs is that the CDs can induce
hemolysis and nephrotoxicity. Consequently, there is a need to
obviate such adverse effects induced by the CDs: in this area,
research is still continuing. For example, concentration-related
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cytotoxicity of β-CDC6, an amphiphilic β-cyclodextrin deriva-
tized nanoparticles, has been demonstrated by using mouse
fibroblasts and human polymorphonuclear cells in culture
(Memisoglu-Bilensoy et al., 2006).
Among the metal nanoparticles, nano-gold particles pos-
sess favorable biocompatibility and stability (Gu et al., 2001,
2002, 2003, 2006). The utility of nano-gold particles was first
highlighted in the immune-gold staining procedures in elec-
tron microscopic applications in the 1970s. But studies on the
effects of the nano-gold particles on proliferation of mammalian
cells only began to emerge in recent years (Lai et al., 2008b).
In 2005, Mukherjee et al. (2005) noted that a novel mecha-
nism by which nano-gold particles inhibited the proliferation
of human umbilical EC cells in vitro was via binding with
heparin-binding proteins. However, the toxicity of the nano-gold
particles could be decreased by functionalizing with peptide of
the sequence Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) (Fuente et al.,
2006).
Ramis-Castelltort et al. (2008) designed a nanostructured
material composed of a gold nanoparticle core functionalized
with hyaluronan (HA) molecules on its surface. They tested this
conjugate based on Gold-HA nanoparticles for cosmetic appli-
cations with the intent to improve features including stability,
skin-penetration and water absorption/retaining effect, but their
results remained to be confirmed. In order to improve the bio-
compatibility of polyethylene terephthalate (PET)mesh, scaffolds
composed of PET-gold nanoparticles (PET-AuNP) were devel-
oped through conjugating various concentrations of AuNP to the
PET surface (Whelove et al., 2011). Their results demonstrated
that exposure of L929 murine fibroblasts to the PET-AuNP scaf-
folds improved their cell integrity, decreased their production of
reactive oxygen species and lowered bacterial adhesion to the PET;
thus, their findings suggested AuNPs could enhance the biocom-
patibility of the PET mesh. Kumari and Singh (2012) synthe-
sized gold nanoflowers (flower-like, three dimensional branched
gold nanoparticles) and constructed glycolic acid-g-chitosan-gold
nanoflower nanocomposite scaffold. The nanohybrid scaffold was
stable at the medium pH and it was biocompatible through
cell (SP2/0 mouse myeloma cell line) viability study. These Au
nanoflowers released the carried drug (cyclophosphamide) at
rates depending on the depth (location) of the nanoparticles in
buffer solution (pH 7.4). Therefore, these gold nanoflowers might
be a viable additive for drug delivery for the glycolic acid grafted
chitosan-based system, but the drug released mechanism in vivo
was not confirmed.
Nano-gold particles can also be used for assay development.
A nanoparticle-based antimicrobial susceptibility assay, utiliz-
ing the concanavalin A-induced clustering of dextran-coated
gold nanoparticles, was developed (Perez et al., 2008). This gold
nanoparticles-based assay reportedly provided reliable and faster
results within 3 h, as compared to conventional methods that
took 24–48 h. Liu et al. (2008) reported a one-step biomolecu-
lar detection method using gold nanoparticle bioconjugates. This
detection method not only permitted the analysis of cancer pro-
tein biomarkers but also potentially allowed the development of
bioassays for fast detection and quantitative analysis of DNAs,
therapeutic drugs and other biological targets.
Silver nanoparticles have been widely used in cosmetic and
medical applications. For example, silver nanoparticles have been
used as an additive to burn-dressing. Depending on the methods
by which they are produced, the physical and chemical proper-
ties of the nanoparticles may significantly differ. Ji et al. (2008)
investigated the effects of two types of silver nanoparticles, those
of colloidal silver and plasma silver, in human periodontal lig-
ament cells. Consistent with the hypothesis stated above was
their finding that the colloidal silver nanoparticles showed higher
toxicity than plasma-generated silver nanoparticles, especially in
inhibiting proliferation of the ligament cells. Another biomedical
application of silver nanoparticles relates to their use in amelio-
rating joint inflammation. Use of the ointment containing silver
nanoparticles led to faster recovery from temporomandibular
joint arthritis (Lee et al., 2008); this beneficial effect was attributed
to the anti-inflammatory action of the silver nanoparticles.
In summary, many nanoparticles appear to show some tox-
icity in various cell types. Consequently, in considering the use
of nanoparticles in pharmaceutical and other biomedical appli-
cations, one should eliminate the putative cytotoxicity of such
particles, which very often exert as a complicating and unde-
sirable characteristic. On the other hand, one can productively
exploit the toxicity of nanoparticles in conjunction with exist-
ing anti-cancer drugs to arrive at improved drug formulations
of combination therapies to enhance their potential and efficacy
for treating different kinds of cancers. All in all, the literature
suggests that the strategic use of combinations of nanomaterials
with other materials may lead to the development of more bio-
compatible materials with the desired characteristics for different
pharmaceutical and other biomedical applications.
APPLICATIONS OF CHITOSAN AND NANOPARTICLES
IN BIOENGINEERING
A recent advance in nanotechnology is the development of a func-
tional nanosystem (such as carbon nanotubes, quantum dots,
polymeric micelles, metallic nanoparticles and liposomes), by
incorporation, adsorption, or covalent coupling of polymers,
carbohydrates, nucleic acids or polysaccharides to the surface
of nanoparticles (Nahar et al., 2006). Various types of func-
tional nanosystems are being extensively explored for diverse
applications in the biomedical field. A major problem in tissue
engineering is high tissue accumulation of non-biodegradable
nanoparticles that may hinder mobility and cause inflamma-
tory/toxicity problems, thus rendering them as “not-so-popular
and not-so-desirable” therapeutic and diagnostic systems. This
pathophysiological condition is presumed to be related to the
immune response elicited by the non-biodegradable nanoparti-
cles and evidently needs further research.
In bioengineering, the layer-by-layer technique used to build
thin polyelectrolyte multilayer films is a new promising approach
to modify biomaterial surfaces (Karakecili et al., 2007). Adopting
this approach, one can combine chitosan with nanoparticles in
current and future applications. For instance, chitosan can be
used to modify nanoparticles; on the other hand, it can also
be functionalized with nanoparticles. The composites of chi-
tosan bonded with nanoparticles may have advantages over chi-
tosan and the bonding materials alone. Chitosan-gold hybrid
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nanospheres and gold nanoparticles encapsulated with chitosan
have been fabricated (Tan and Zhang, 2005; Guo et al., 2008).
Because these hybrid composites are relatively new materi-
als, their putative toxicity has yet to be determined. Similarly,
biomedical applications of these materials remain to be devel-
oped: presumably cell culture systems in vitro may be suitably
employed for assisting such developments.
PHARMACEUTICAL APPLICATIONS OF CHITOSAN AND
NANOPARTICLES
Because of good biocompatibility, chitosan has excellent poten-
tial in numerous pharmaceutical applications; consequently, it
has captured the attention of researchers in pharmaceutical sci-
ences (Dodane and Vilivalam, 1998). The fact that chitosan is
highly biocompatible, biodegradable, and shows the ability to
open intercellular tight junctions renders it an almost ideal can-
didate for formulating drugs for oral delivery (Berradaa et al.,
2005). For example, a chitosan-dibasic orthophosphate hydro-
gel has been formulated and synthesized (Ta et al., 2009). The
potential of employing this gel as a prolonged drug deliv-
ery vehicle was demonstrated using fluorescein isothiocyanate-
dextran, β-lactoglobulin and bovine serum albumin. Moreover,
this hydrogel was not toxic to SaOS-2 (human epithelial-like
osteosarcoma) cells.
Nanoparticulate delivery system has the potential to improve
drug stability, increase the duration of the therapeutic effect and
permit administration through non-parental routes. Sarmento
et al. (2007a,b) prepared alginate/chitosan nanoparticles and
dextran sulfate/chitosan nanoparticles for use in oral insulin
delivery. They found that the nanoparticles significantly lowered
serum glucose levels in streptozotocin-induced diabetic rats at
insulin doses of 50 and 100 IU/kg. The hypoglycemic effect and
insulinemia levels were considerably better than those obtained
from oral insulin administration alone. Their results indicated
that alginate/chitosan nanoparticles and dextran sulfate/chitosan
nanoparticles showed favorable characteristics as agents to be
employed for formulating oral delivery system for insulin and
potentially for other therapeutical proteins. Rekha and Sharma
(2009) synthesized and evaluated lauryl succinyl chitosan parti-
cles for the applications in oral insulin delivery and absorption.
Their results demonstrated that the chitosan particles modified
with both hydrophilic (i.e., succinyl) and hydrophobic (i.e., lau-
ryl) moieties had improved the release characteristics, mucoadhe-
siveness as well as the permeability of insulin compared to those
of the native chitosan particles. Thus, their findings suggested that
these novel chitosan derivatives may be promising candidates for
oral peptide delivery.
Chitosan has also been employed to enhance drug efficacy,
especially in formulating anti-cancer drugs. Kim et al. (2008)
developed self-assembled glycol chitosan (HGC) nanoparticles
for the sustained and prolonged delivery of anti-angiogenic small
peptide (containing the anti-angiogenic Arg-Gly-Asp (RGD) pep-
tide) drugs in cancer therapy. They observed that intravenous and
intratumoral administration of RGD-HGC nanoparticles into
B16F10 tumor-bearing mice resulted in significant decreases in
tumor growth and microvessel density compared with corre-
sponding parameters in the tumor-bearing mice injected with
native RGD peptide. Thus, their findings suggested the HGC
nanoparticles may be valuable in anti-angiogenic therapy and
for local and regional tumor therapy. HGC nanoparticles loaded
with the anticancer drug docetaxel (DTX) were investigated by
Hwang et al. (2008). The DTX-HGC nanoparticles exhibited
higher anti-tumor efficacy as indicated by reduced tumor vol-
ume and increased survival rate in mice bearing A549 lung cancer
cells. Furthermore, the formulation of DTX-HGC nanoparticles
resulted in decreased toxicity of DTX inmice compared to toxicity
of free DTX in tumor-bearing mice. Consequently, their findings
suggested that this type of nano-sized drug carriers may be ideal
for formulating drugs for cancer treatment.
A new type of drug delivery system (DDS) involved chitosan-
modified single walled carbon nanotubes (SWNTs) for control-
lable loading/release of an anti-cancer drug, doxorubicin (DOX)
(Ji et al., 2011). The DDS containing DOX could effectively kill
the HepG2 SMMC-7721 cells and depress the growth of liver can-
cer in tumor-bearing nude mice. Thus, this finding demonstrated
that the efficacy of the chitosan-containing DDS with DOX was
superior to that of free DOX and suggested that the chitosan-
containing DDS holds promise for delivering anti-cancer drugs
because of its improved efficacy and low side effects.
CONCLUSIONS
As a biocompatiblematerial, chitosan has foundmany and diverse
biomedical applications. Nevertheless, there are lots of room for
improvement in mechanical properties and biocompatibility of
chitosan before it becomes an ideal biomaterial for biomedi-
cal and tissue engineering applications. For instance, blending
chitosan with other polymers can improve its properties and
vice versa. Chitosan can also be used to modify other materials
to enhance their biocompatibility. On the other hand, chitosan
can induce both stimulatory and inhibitory effects on fibrob-
lasts and several other cell types. These contrasting data could
be attributed, at least in part, to dissimilar properties and chem-
ical compositions of the biopolymers employed, thus rending it
difficult to derive molecular mechanisms underlying such dissim-
ilar effects of chitosan. By the same token, blending chitosan with
other biopolymers can very well complement what chitosan can-
not achieve alone biocompatibilitywise. Consequently, there is a
definite need for a systematic approach to categorically classify all
the aforementioned parameters.
Due to the ubiquitous existence of nanomaterials, human
exposure to nanoparticles is inevitable. Nanoparticles can enter
the body through lungs, skin, or via the gastrointestinal track
with intake of food, drinks, and medications, or simply by direct
exposure to adverse environment such as working in a dusty tun-
nel. These particles can affect brain, liver, kidney, heart, blood,
and other organs and tissues. They are known to induce many
cytotoxic effects on neural and non-neural cell types. They may
distort and inhibit cell growth leading to various pathophysiolog-
ical states in humans and animals. Consequently, nanotoxicology
research is now becoming an important endeavor and is gaining
and receiving much more attention in the biomedical field.
Before a new material can be employed for tissue engineering
or other biomedical applications, it is necessary to test its biocom-
patibility and/or putative toxicity. Cell cultural models in vitro
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constitute convenient systems for high throughput screening of
the putative toxicity of nanoparticles and other nanomaterials
(Rajaraman et al., 1974; Lai et al., 2007, 2008a, 2009, 2010; Jaiswal
et al., 2010, 2011; Jain et al., 2011; Lu et al., 2011). Use of these cell
models is relatively inexpensive as compared to the use of animal
models. The knowledge obtained from the research can lead to
prevention of human exposure to nanoparticles and/or nanoma-
terials that are proven hazardous. Thus far, many nanoparticles
show some toxicity to some cell types. Consequently, one needs to
pay more attention to the cytotoxicity of nanoparticles and other
nanomaterials. On the other hand, one can exploit the inhibitory
effects of nanoparticles on cell survival in cancer chemotherapy
and drug treatment. Nevertheless, evaluation of nanotoxicity with
standard protocols is an urgent issue as more nanomaterials are
being used in industry: that includes exposure to workers in con-
fined quarters as well as to the public in an open environment.
Whilst cell models are viewed to be the most viable means to pur-
suit nanotoxicity, the traditional discussion of the pros and cons
of cell model versus animal model still persist and is beyond the
scope of this review.
Biopolymer films, either based on chitosan itself or chitosan
binding with other polymers, have been demonstrated to work
well with various types of cells in culture: this encouraging char-
acteristic of chitosan holds promise for a variety of applications in
current and future developments of tissue engineering. However,
it would be unrealistic to expect that chitosan and its deriva-
tives would fulfill all the needs in tissue and bioengineering.
Most of our organs and tissues are multifunctional; there are
receptors and organelles on or beneath the surface of the tissues
and cells that function interactively in networks to either pro-
mote or suppress biological activities so that our bodily functions
can be properly controlled. In fact, these push-pull properties
from the multifaceted observations of chitosan and its aforemen-
tionedmodified formsmimic certain characteristics of tissues and
organs. This biomimicry provides a foundation that researchers
can build upon. From a tissue engineering point of view, sci-
entific advances have been made in great strides in the last few
decades, but the overall state of the art is still in the develop-
mental stage as compared to the development of the electronic
industry. One should expect that the development of bioengineer-
ing be at a slower rate due to the complexity and variability of
the biosystems. To say the least, research needs and opportuni-
ties in tissue and bioengineering are abundant now and in the
foreseeable future.
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